Dr. Mete Korkmaz, MD

  • Rockford, IL
  • Medical oncologist
NPI1902833999PAC ID7517967508
Medicare services, 2024
1,892
Medicare patients, 2024
553
Part D claims, 2024
1,956
Publications
1
Hospital affiliations
4
Practice address
5666 East State Street, Rockford, IL 61108
Practice phone
Call (815) 226-2000
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

OSF Saint Anthony Medical Center

Hospital · Rockford, Illinois

See all 7 affiliations

Find Dr. Korkmaz's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Mete Korkmaz is a medical oncologist in Rockford, Illinois

Dr. Korkmaz practices at OSF Saint Anthony Medical Center in Rockford, Illinois, part of OSF HealthCare System.

Dr. Korkmaz's NPI, 1902833999, was assigned on June 27, 2006. Dr. Korkmaz holds Illinois license 036091602.

NPI and contact details
Medicare PAC ID
7517967508
NPI enumeration date
June 27, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(815) 226-2000
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
66
Medical school graduation
1986

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Mete Korkmaz practices at OSF Saint Anthony Medical Center in Rockford, Illinois

Dr. Korkmaz's primary practice is OSF Saint Anthony Medical Center, at 5666 East State Street, Rockford, IL 61108 in Winnebago County. The practice phone is (815) 226-2000.

Source: Dmand AI Affiliation Data

Dr. Mete Korkmaz is affiliated with 4 sites of care and 3 medical groups

Dr. Korkmaz's primary practice is OSF Saint Anthony Medical Center in Rockford, Illinois, part of OSF HealthCare System. Dr. Korkmaz is also affiliated with OSF Saint Elizabeth Medical Center - Peru. The medical group on file is OSF Multi-Specialty Group. Dmand AI also links Dr. Korkmaz to 2 more hospitals and 2 medical groups, each named with a free account.

See all 7 affiliations for Dr. Korkmaz

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Mete Korkmaz's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Korkmaz practices, 4 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
OSF Saint Anthony Medical CenterAvailable with a free account
+3 more sites and 2 medical groupsAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Korkmaz practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across OSF HealthCare System and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Mete Korkmaz is one of 153 medical oncologists in Illinois

Medical oncology is Dr. Korkmaz's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Korkmaz is licensed in Illinois.

Specialties and state licenses

  • Medical oncology, IllinoisPrimaryLicense 036091602 · taxonomy 207RX0202X

Medical oncologists near Dr. Korkmaz

Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Mete Korkmaz billed Medicare for 1,892 services in 2024

CMS data shows 1,892 Medicare services from Dr. Korkmaz across 8 procedure codes in 2024, for 553 Medicare patients. Medicare paid $127,494 for them. Every service was in a facility, such as a hospital, rather than an office.

Medicare services, 20241,892
Medicare patients553
Paid by Medicare$127,494
Procedure codes8

Dr. Korkmaz's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 1,7842024: 1,8926%

Dr. Korkmaz compared with the Illinois median for medical oncologists, 2024

  • Dr. Korkmaz
  • Illinois median
Medicare services
1,892vs 6712.8 times
Medicare patients
553vs 2302.4 times
Part D claims
1,626vs 3454.7 times

Medians across 140 medical oncologists in Illinois with Dmand AI profiles that report each measure.

Dr. Korkmaz's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Korkmaz

Need commercial claims for Dr. Korkmaz?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Korkmaz and other medical oncologists in Illinois.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Mete Korkmaz treated 553 Medicare patients in 2024, average age 76

CMS counts 553 Medicare patients who saw Dr. Korkmaz in 2024. The largest group is 65 to 74, with 226 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Korkmaz's median patient age at 75, with 57% women.

Medicare patients, 2024553
Average age76
Average risk score1.93
Also on Medicaid14%

Dr. Korkmaz's Medicare patients by age, 2024

Dr. Korkmaz's Medicare patients by sex, 2024

  • Women30054%
  • Men25346%

Chronic conditions among Dr. Korkmaz's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Arthritis47%
  4. Cancer44%
  5. Chronic kidney disease38%
  6. Diabetes38%
  7. Ischemic heart disease37%
  8. COPD31%

Share of Medicare patients with each condition. A patient can have several.

Dr. Korkmaz's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 75

Patient panel by sex, all payers

  • Women57%
  • Men42%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Mete Korkmaz wrote 1,956 Medicare Part D claims in 2024

In 2024, Dr. Korkmaz wrote 1,956 Medicare Part D claims for 322 patients. 75% of them were for generic drugs. CMS names the drug for 1,626 of them, across 42 drugs with 11 or more claims each, at $4,079,955 in total drug cost. In 2023, CMS named 1,615 claims across 42 drugs.

Part D claims, 20241,956
Drugs named by CMS42
Total drug cost$4.1M
Part D patients322

Dr. Korkmaz's Part D claims by kind of drug, 2024

  • Generic1,459 claims75%
  • Brand-name497 claims25%

Dr. Korkmaz's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Korkmaz's Part D claims, 2024

  • Opioids8%155 of 1,956 claims
  • Antibiotics3%50 of 1,956 claims
  • Antipsychotics, patients 65 and over2%30 of 1,956 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 1,6152024: 1,6261%

Drugs named by CMS: 42 in 2024, 42 in 2023.

See all prescribing by Dr. Korkmaz

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

How Dr. Mete Korkmaz takes part in Medicare

Dr. Korkmaz accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Source: Doctors and Clinicians National Downloadable File (CMS)

For MedTech and pharma teams

Find medical oncologists like Dr. Korkmaz by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Mete Korkmaz has 1 publication on record

Dmand AI links 1 paper to Dr. Korkmaz in 2020. Dr. Korkmaz's most frequent co-authors are Paul David Martin, MD, Simona Rossi, MD and Atif Zaman, MD.

Papers1

Dr. Korkmaz's most frequent co-authors

Recent publications by Dr. Korkmaz

See all 1 publications and co-authors

See who Dr. Korkmaz researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Korkmaz works with, so you can find a warm path to the right medical oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Mete Korkmaz received $57,686 in industry payments from 2016 to 2025

CMS Open Payments shows 25 general payments to Dr. Korkmaz from 14 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 97% of the total. Bristol-Myers Squibb Company paid the most, $47,832.

General payments to Dr. Korkmaz by program year, 2016 to 2025

General payments to Dr. Korkmaz by kind, 2016 to 2025

$57.7Kin total
  • Consulting fees$55,86097%
  • Food and beverage$1,2342%
  • Travel and lodging$3281%
  • Honoraria$1750%
  • Education$890%

Companies that paid Dr. Korkmaz the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Korkmaz

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Dr. Mete Korkmaz's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Mete Korkmaz

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Mete Korkmaz's NPI number?

Dr. Mete Korkmaz's NPI number is 1902833999. It was assigned on June 27, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Mete Korkmaz?

Dr. Mete Korkmaz is a medical oncologist in Rockford, Illinois. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).

Where does Dr. Mete Korkmaz practice?

Dr. Korkmaz practices at 5666 East State Street, Rockford, IL 61108. Dr. Korkmaz's primary practice is OSF Saint Anthony Medical Center in Rockford, Illinois, part of OSF HealthCare System. Dmand AI also links Dr. Korkmaz to 2 hospitals and 2 medical groups.

What is Dr. Mete Korkmaz's office phone number?

The practice phone on file for Dr. Korkmaz is (815) 226-2000.

What is Dr. Mete Korkmaz's medical license number?

Dr. Korkmaz holds Illinois license 036091602.

Which hospitals is Dr. Mete Korkmaz affiliated with?

Dr. Korkmaz practices at OSF Saint Anthony Medical Center in Rockford, Illinois. Dr. Korkmaz is also affiliated with OSF Saint Elizabeth Medical Center - Peru. Dmand AI links Dr. Korkmaz to 2 more hospitals.

What medical group is Dr. Mete Korkmaz part of?

Dr. Korkmaz is linked to OSF Multi-Specialty Group. Dmand AI links Dr. Korkmaz to 2 more medical groups.

Does Dr. Mete Korkmaz accept Medicare?

Yes. CMS data shows Dr. Korkmaz billed Medicare for 1,892 services in 2024, and Dr. Korkmaz accepts Medicare assignment.

How many Medicare patients does Dr. Mete Korkmaz see?

CMS counts 553 Medicare patients who saw Dr. Korkmaz in 2024, with an average age of 76.

What services does Dr. Mete Korkmaz bill to Medicare?

In 2024, Dr. Korkmaz's most billed Medicare services were office visit, established patient (99214), office visit, established patient (99213) and hospital inpatient care (99232).

Show 5 more questionsShow fewer questions

What drugs does Dr. Mete Korkmaz prescribe most?

In 2024 Medicare Part D data, Dr. Korkmaz's most prescribed drugs by claims were Anastrozole, Ondansetron HCl and Prochlorperazine Maleate.

Has Dr. Mete Korkmaz received payments from drug or device companies?

CMS Open Payments shows $57,686 in general payments to Dr. Korkmaz from 14 companies from 2016 to 2025. The largest total came from Bristol-Myers Squibb Company.

How long has Dr. Mete Korkmaz been practicing?

Dr. Korkmaz graduated from medical school in 1986, 40 years ago.

Does Dr. Mete Korkmaz do research?

Dmand AI links 1 publication to Dr. Korkmaz.

Who does Dr. Mete Korkmaz publish with?

Dr. Korkmaz's most frequent co-authors are Paul David Martin, MD (1 shared paper), Simona Rossi, MD (1 shared paper) and Atif Zaman, MD (1 shared paper).

Selling to medical oncology practices?

See medical oncologists in Illinois by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)